Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Reductions in stillbirths and preterm birth in COVID-19 vaccinated women: a multi-center cohort study of vaccination uptake and perinatal outcomes

View ORCID ProfileLisa Hui, View ORCID ProfileMelvin Barrientos Marzan, View ORCID ProfileDaniel L. Rolnik, View ORCID ProfileStephanie Potenza, View ORCID ProfileNatasha Pritchard, View ORCID ProfileJoanne M. Said, View ORCID ProfileKirsten R Palmer, View ORCID ProfileClare L. Whitehead, View ORCID ProfilePenelope M. Sheehan, Jolyon Ford, View ORCID ProfileBen W. Mol, View ORCID ProfileSusan P. Walker
doi: https://doi.org/10.1101/2022.07.04.22277193
Lisa Hui
1Department of Obstetrics and Gynaecology, Melbourne Medical School, The University of Melbourne, Parkville, VIC 3052, Australia
2Reproductive Epidemiology Group, Murdoch Children’s Research Institute, Parkville VIC 3052 Australia
3Department of Obstetrics and Gynaecology, Mercy Hospital for Women, Mercy Health, Heidelberg VIC 3084 Australia
4Department of Obstetrics and Gynaecology, The Northern Hospital, Northern Health, Epping VIC 3076 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lisa Hui
  • For correspondence: lisa.hui{at}unimelb.edu.au
Melvin Barrientos Marzan
1Department of Obstetrics and Gynaecology, Melbourne Medical School, The University of Melbourne, Parkville, VIC 3052, Australia
2Reproductive Epidemiology Group, Murdoch Children’s Research Institute, Parkville VIC 3052 Australia
5Center for Alcohol Policy Research (CAPR), La Trobe University, Bundoora VIC 3086 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Melvin Barrientos Marzan
Daniel L. Rolnik
6Department of Obstetrics and Gynaecology, Monash Health, Clayton VIC 3168
7Department of Obstetrics and Gynaecology, Monash University, Clayton VIC 3168
12Harvard School of Public Health, Harvard University, Cambridge MA, 02115 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel L. Rolnik
Stephanie Potenza
3Department of Obstetrics and Gynaecology, Mercy Hospital for Women, Mercy Health, Heidelberg VIC 3084 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephanie Potenza
Natasha Pritchard
1Department of Obstetrics and Gynaecology, Melbourne Medical School, The University of Melbourne, Parkville, VIC 3052, Australia
3Department of Obstetrics and Gynaecology, Mercy Hospital for Women, Mercy Health, Heidelberg VIC 3084 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natasha Pritchard
Joanne M. Said
1Department of Obstetrics and Gynaecology, Melbourne Medical School, The University of Melbourne, Parkville, VIC 3052, Australia
8Maternal-Fetal Medicine Department, Joan Kirner Women’s and Children’s Hospital, Western Health, St Albans VIC 3021 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joanne M. Said
Kirsten R Palmer
6Department of Obstetrics and Gynaecology, Monash Health, Clayton VIC 3168
7Department of Obstetrics and Gynaecology, Monash University, Clayton VIC 3168
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kirsten R Palmer
Clare L. Whitehead
1Department of Obstetrics and Gynaecology, Melbourne Medical School, The University of Melbourne, Parkville, VIC 3052, Australia
9Department of Obstetrics and Gynaecology, the Royal Women’s Hospital, Parkville VIC 3052 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Clare L. Whitehead
Penelope M. Sheehan
7Department of Obstetrics and Gynaecology, Monash University, Clayton VIC 3168
10Department of Obstetrics and Gynaecology, Box Hill Hospital, Eastern Health, Box Hill VIC 3128 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Penelope M. Sheehan
Jolyon Ford
11Department of Obstetrics and Gynaecology, Frankston Hospital, Peninsula Health VIC 3199, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben W. Mol
6Department of Obstetrics and Gynaecology, Monash Health, Clayton VIC 3168
7Department of Obstetrics and Gynaecology, Monash University, Clayton VIC 3168
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ben W. Mol
Susan P. Walker
1Department of Obstetrics and Gynaecology, Melbourne Medical School, The University of Melbourne, Parkville, VIC 3052, Australia
3Department of Obstetrics and Gynaecology, Mercy Hospital for Women, Mercy Health, Heidelberg VIC 3084 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Susan P. Walker
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background COVID-19 infection in pregnancy is associated with a higher risk of progression to severe disease, but vaccine uptake by pregnant women is hindered by persistent safety concerns. COVID-19 vaccination in pregnancy has been shown to reduce stillbirth, but its relationship with preterm birth is uncertain.

Objective The aim of this study was to investigate the sociodemographic characteristics associated with vaccine uptake in Melbourne, Australia, and to compare perinatal outcomes by vaccination status.

Study design Retrospective multicenter cohort study in Melbourne following the national recommendations for mRNA COVID-19 vaccination during pregnancy in June 2021. Routinely collected data from all 12 public maternity hospitals in Melbourne were extracted on births ≥ 20 weeks’ gestation from 1st July 2021 to 31 March 2022. Maternal sociodemographic characteristics were analyzed from the total birth cohort. Perinatal outcomes were compared between vaccinated and unvaccinated women for whom weeks 20-43 of gestation fell entirely within the 9-month data collection period. The primary outcome was the rate of congenital anomaly in singleton infants ≥ 20 weeks’ gestation among women vaccinated during pregnancy. Secondary perinatal outcomes including stillbirth, preterm birth (spontaneous and iatrogenic), birthweight ≤ 3rd centile, and newborn intensive care unit admissions were examined for singleton infants ≥ 24 weeks’ gestation without congenital anomalies. We calculated the adjusted odds ratio of congenital anomalies and perinatal outcomes among vaccinated versus unvaccinated women using inverse propensity score weighting regression adjustment with multiple covariates; p< 0.05 was considered statistically significant.

Results Births from 32,536 women were analyzed: 17,365 (53.4%) were vaccinated and 15,171 (47.6%) were unvaccinated. Vaccinated women were significantly more likely to be older, nulliparous, non-smoking, not requiring an interpreter, of higher socioeconomic status, and vaccinated against pertussis and influenza. Vaccination status also varied by region of birth: compared with women born in Australia, women born in South and Eastern Europe, the Middle East, Africa and Oceania had lower adjusted odds of vaccination. There was no significant increase in the rate of congenital anomalies or birth weight ≤ 3rd centile in vaccinated women. Vaccinated women were significantly less like to have an infant with a major congenital anomaly compared with the unvaccinated group (2.4% vs 3.0%, aOR 0.72, 95%CI 0.56-0.94, p=0.02). This finding remained significant even when the analysis was restricted to women vaccinated before 20 weeks’ gestation. Vaccinated women had a significantly lower rate of stillbirth (0.2% vs 0.8%, aOR 0.18, 95%CI 0.09-0.37, P < 0.001. Vaccination was associated with a significant reduction in total preterm births < 37 weeks (5.1% vs 9.2%, aOR 0.60, 95% CI 0.51-0.71, p< 0.001), spontaneous preterm birth (2.4% vs 4.0%, aOR 0.73 95% CI 0.56-0.96, p=0.02) and iatrogenic preterm birth (2.7% vs 5.2%, aOR 0.52, 95%CI 0.41-0.65, p< 0.001).

Conclusions COVID-19 Vaccine coverage was significantly influenced by known social determinants of health, which is likely to influence the strong association between COVID-19 vaccination and lower risks of stillbirth and preterm birth. We did not observe any adverse impacts of vaccination on fetal growth or development.

Why was this study conducted?

  • ⍰ COVID-19 infection in pregnancy is associated with a higher risk of progression to severe disease, but vaccine uptake by pregnant women is hindered by persistent safety concerns. COVID-19 vaccination in pregnancy has been shown to reduce stillbirth, but its relationship with preterm birth is uncertain.

  • ⍰ Most of the published literature on COVID-19 vaccination in pregnancy have methodological limitations including fixed cohort bias and time-varying exposure.

  • ⍰ We conducted this multicenter study to provide robust evidence on mRNA COVID-19 vaccination and perinatal outcomes including congenital anomalies, stillbirth, and preterm birth.

What are the key findings?

  • ⍰ The adjusted odds of stillbirth, preterm birth, and neonatal intensive care admission were significantly reduced among infants born to COVID-19 vaccinated women compared with unvaccinated women. COVID-19 vaccination during pregnancy was not associated with an increase in congenital anomalies.

  • ⍰ Our results conclusively demonstrate a significant reduction in both spontaneous and iatrogenic preterm birth for vaccinated women

  • ⍰ Vaccinated women were significantly more likely to be older, nulliparous, non-smoking, not requiring an interpreter, residing in a higher socioeconomic postcode, and vaccinated against pertussis and influenza. There were also significant differences in vaccination rates by region of birth.

What does this study add to what is already known?

  • ⍰ Our analysis confirmed a strong relationship between the COVID-19 mRNA vaccine and lower preterm births and stillbirths

  • ⍰ In addition to its impact on reducing severe COVID-19 illness, vaccination may be a proxy for other biological and social determinants of health among our pregnant population.

Competing Interest Statement

LH has received research funding from Ferring Pharmaceuticals outside the scope of this work. BWM is a consultant for Guerbet and has received research grants from Guerbet and Merck. KRP has received consultancy fees from Janssen. DLR has received fees from Alexion for participation in advisory boards unrelated to this work. All other authors declare no competing interests.

Funding Statement

This study was funded by the Norman Beischer Medical Research Foundation and the University of Melbourne Department of Obstetrics and Gynaecology. LH, BWM and KRP are supported by National Health and Medical Research Council investigator grants (GNT1196010, GNT11766437 and GNT2009765). The funding bodies had no role in any aspects of the design or conduct of this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was given ethical approval from the Human Research Ethics Committees of Austin Health (Ref. HREC/64722/Austin-2020) and Mercy Health (Ref. 2020-031).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • DISCLOSURES LH has received research funding from Ferring Pharmaceuticals outside the scope of this work. BWM is a consultant for Guerbet and has received research grants from Guerbet and Merck. KRP has received consultancy fees from Janssen. DLR has received fees from Alexion for participation in advisory boards unrelated to this work. All other authors declare no competing interests.

  • FUNDING This study was funded by the Norman Beischer Medical Research Foundation and the University of Melbourne Department of Obstetrics and Gynaecology. LH, BWM and KRP are supported by National Health and Medical Research Council investigator grants (GNT1196010, GNT11766437 and GNT2009765). The funding bodies had no role in any aspects of the design or conduct of this study.

  • PAPER PRESENTATION The findings of this study were submitted as a free communication for the Annual Scientific Meeting of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists at the Gold Coast, QLD, Australia in October 2022.

  • CONDENSATION Stillbirths, spontaneous and iatrogenic preterm births significantly lower in COVID-19 vaccinated women

  • An error in figure 8 has been noted - the incorrect set of 'numbers at risk' were duplicated across both plots - the correct numbers have now been placed. The hazard ratio analysis remains correct.

Data Availability

Non-identifiable individual participant data is available on request to the Austin Health Human Research Ethics Committee (ethics{at}austin.org.au) and the Mercy Health Human Research Ethics Committee (ethics{at}mercy.com.au). The study investigators may contribute aggregate and non-identifiable individual patient data to national and international collaborations whose proposed use of the data has been ethically reviewed and approved by an independent committee and following signing of an appropriate research collaboration agreement with the University of Melbourne.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 12, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Reductions in stillbirths and preterm birth in COVID-19 vaccinated women: a multi-center cohort study of vaccination uptake and perinatal outcomes
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Reductions in stillbirths and preterm birth in COVID-19 vaccinated women: a multi-center cohort study of vaccination uptake and perinatal outcomes
Lisa Hui, Melvin Barrientos Marzan, Daniel L. Rolnik, Stephanie Potenza, Natasha Pritchard, Joanne M. Said, Kirsten R Palmer, Clare L. Whitehead, Penelope M. Sheehan, Jolyon Ford, Ben W. Mol, Susan P. Walker
medRxiv 2022.07.04.22277193; doi: https://doi.org/10.1101/2022.07.04.22277193
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Reductions in stillbirths and preterm birth in COVID-19 vaccinated women: a multi-center cohort study of vaccination uptake and perinatal outcomes
Lisa Hui, Melvin Barrientos Marzan, Daniel L. Rolnik, Stephanie Potenza, Natasha Pritchard, Joanne M. Said, Kirsten R Palmer, Clare L. Whitehead, Penelope M. Sheehan, Jolyon Ford, Ben W. Mol, Susan P. Walker
medRxiv 2022.07.04.22277193; doi: https://doi.org/10.1101/2022.07.04.22277193

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Obstetrics and Gynecology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13337)
  • Forensic Medicine (19)
  • Gastroenterology (896)
  • Genetic and Genomic Medicine (5128)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3251)
  • Health Policy (1137)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1012)
  • Infectious Diseases (except HIV/AIDS) (14611)
  • Intensive Care and Critical Care Medicine (908)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (521)
  • Neurology (4898)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (879)
  • Occupational and Environmental Health (795)
  • Oncology (2515)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (537)
  • Pediatrics (1297)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4189)
  • Public and Global Health (7482)
  • Radiology and Imaging (1700)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (545)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)